The crystal structure of the non-liganded 14-3-3σ protein:: insights into determinants of isoform specific ligand binding and dimerization

被引:95
作者
Benzinger, A
Popowicz, GM
Joy, JK
Majumdar, S
Holak, TA
Hermeking, H
机构
[1] Max Planck Inst Biochem, Mol Oncol Grp, D-82152 Martinsried, Germany
[2] Max Planck Inst Biochem, NMR Grp, D-82152 Martinsried, Germany
关键词
14-3-3; sigma; p53; crystal structure; tumor suppression; 14-3-3 isoform specificity;
D O I
10.1038/sj.cr.7290290
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Seven different, but highly conserved 14-3-3 proteins are involved in diverse signaling pathways in human cells. It is unclear how the 14-3-3 sigma isoform, a transcriptional target of p53, exerts its inhibitory effect on the cell cycle in the presence of other 14-3-3 isoforms, which are constitutively expressed at high levels. In order to identify structural differences between the 14-3-3 isoforms, we solved the crystal structure of the human 14-3-3 sigma protein at a resolution of 2.8 A and compared it to the known structures of 14-3-3 zeta and 14-3-3 tau. The global architecture of the 14-3-3(5 fold is similar to the previously determined structures of 14-3-3 zeta and 14-3-3 tau: two 14-3-3 sigma molecules form a cup-shaped dimer. Significant differences between these 14-3-3 isoforms were detected adjacent to the amphipathic groove, which mediates the binding to phosphorylated consensus motifs in 14-3-3-ligands. Another specificity determining region is localized between amino-acids 203 to 215. These differences presumably select for the interaction with specific ligands, which may explain the different biological functions of the respective 14-3-3 isoforms. Furthermore, the two 14-3-3(7 molecules forming a dimer differ by the spatial position of the ninth helix, which is shifted to the inside of the ligand interaction surface, thus indicating adaptability of this part of the molecule. In addition, 5 non-conserved residues are located at the interface between two 14-3-3 sigma proteins forming a dimer and represent candidate determinants of homo and hetero-dimerization specificity. The structural differences among the 14-3-3 isoforms described here presumably contribute to isoform- specific interactions and functions.
引用
收藏
页码:219 / 227
页数:9
相关论文
共 30 条
[1]   Specificity of 14-3-3 isoform dimer interactions and phosphorylation [J].
Aitken, A ;
Baxter, H ;
Dubois, T ;
Clokie, S ;
Mackie, S ;
Mitchell, K ;
Peden, A ;
Zemlickova, E .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2002, 30 :351-360
[2]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[3]  
BENZINGER A, 2005, MOL CELL PROTEO 0318
[4]   14-3-3σ is required to prevent mitotic catastrophe after DNA damage [J].
Chan, TA ;
Hermeking, H ;
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B .
NATURE, 1999, 401 (6753) :616-620
[5]   High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer [J].
Ferguson, AT ;
Evron, E ;
Umbricht, CB ;
Pandita, TK ;
Chan, TA ;
Hermeking, H ;
Marks, JR ;
Lambers, AR ;
Futreal, PA ;
Stampfer, MR ;
Sukumar, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (11) :6049-6054
[6]   The 14-3-3 cancer connection [J].
Hermeking, H .
NATURE REVIEWS CANCER, 2003, 3 (12) :931-943
[7]   14-3-3σ is a p53-regulated inhibitor of G2/M progression [J].
Hermeking, H ;
Lengauer, C ;
Polyak, K ;
He, TC ;
Zhang, L ;
Thiagalingam, S ;
Kinzler, KW ;
Vogelstein, B .
MOLECULAR CELL, 1997, 1 (01) :3-11
[8]   Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 σ gene in human hepatocellular carcinoma [J].
Iwata, N ;
Yamamoto, H ;
Sasaki, S ;
Itoh, F ;
Suzuki, H ;
Kikuchi, T ;
Kaneto, H ;
Iku, S ;
Ozeki, I ;
Karino, Y ;
Satoh, T ;
Toyota, J ;
Satoh, M ;
Endo, T ;
Imai, K .
ONCOGENE, 2000, 19 (46) :5298-5302
[9]   AUTOMATIC PROCESSING OF ROTATION DIFFRACTION DATA FROM CRYSTALS OF INITIALLY UNKNOWN SYMMETRY AND CELL CONSTANTS [J].
KABSCH, W .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1993, 26 :795-800
[10]   AUTOMATED REFINEMENT OF PROTEIN MODELS [J].
LAMZIN, VS ;
WILSON, KS .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1993, 49 :129-147